House FDA reform proposals unveiled
This article was originally published in Clinica
Executive Summary
A series of bipartisan proposals to streamline the FDA's regulatory process was unveiled by a House "FDA reform leadership team" headed by Rep James Greenwood on Capitol Hill on March 27th. Three separate bills have been drawn up - one specifically addressing medical devices which will be directed by Joe Barton (R-Tx), chairman of the oversight subcommittee.